Atara Biotherapeutics Inc
ATRA17.320USD
+0.150+0.87%
Market hours （ET）Quotes delayed by 15 min
124.88MMarket Cap
5.99P/E TTM
Atara Biotherapeutics Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
128.94M
1404.02%
EPS(YoY)
-11.41
82.50%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Atara Biotherapeutics Inc?
According to Atara Biotherapeutics Inc's FY2024 earnings report, its total revenue reached 128.94M, with a year-on-year change of 1404.02%.
What is the Earnings Per Share (EPS) of Atara Biotherapeutics Inc?
According to Atara Biotherapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -11.405, with a year-on-year change of 82.50%.
What is the net income of Atara Biotherapeutics Inc?
According to Atara Biotherapeutics Inc's FY2024 earnings report, its net income was -85.40M, with a year-on-year change of 69.07%.
What is the net margin of Atara Biotherapeutics Inc?
According to Atara Biotherapeutics Inc's FY2024 earnings report, its net profit margin was -66.23%, with a year-on-year change of 97.94%.
What is the gross margin of Atara Biotherapeutics Inc?
According to Atara Biotherapeutics Inc's FY2024 earnings report, its gross margin was 83.71%, with a year-on-year change of 2392.70%.
What is the debt-to-asset ratio of Atara Biotherapeutics Inc?
According to Atara Biotherapeutics Inc's FY2024 earnings report, its debt-to-asset ratio was 37.82%, with a year-on-year change of 64.07%.
What is the Return on Equity (ROE) of Atara Biotherapeutics Inc?
According to Atara Biotherapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was --, with a year-on-year change of --.
What is the Return on Assets (ROA) of Atara Biotherapeutics Inc?
According to Atara Biotherapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was -62.20%, with a year-on-year change of 38.96%.
What is the operating profit of Atara Biotherapeutics Inc?
According to Atara Biotherapeutics Inc's FY2024 earnings report, its operating profit was -78.33M, with a year-on-year change of 70.91%.
What are the current assets of Atara Biotherapeutics Inc?
According to Atara Biotherapeutics Inc's FY2024 earnings report, its current assets were 64.89M, with a year-on-year change of -36.30%.
What are the total assets of Atara Biotherapeutics Inc?
According to Atara Biotherapeutics Inc's FY2024 earnings report, its total assets of Atara Biotherapeutics Inc were 109.10M, with a year-on-year change of -34.08%.
What are the total liabilities of Atara Biotherapeutics Inc?
According to Atara Biotherapeutics Inc's FY2024 earnings report, its total liabilities of Atara Biotherapeutics Inc were 206.38M, with a year-on-year change of -22.04%.
What is the total equity of Atara Biotherapeutics Inc?
According to Atara Biotherapeutics Inc's FY2024 earnings report, its total equity of Atara Biotherapeutics Inc was -97.28M, with a year-on-year change of 1.96%.
What is the net operating income of Atara Biotherapeutics Inc?
According to Atara Biotherapeutics Inc's FY2024 earnings report, its net operating income of Atara Biotherapeutics Inc was -85.40M, with a year-on-year change of 69.07%.
What is the net investment of Atara Biotherapeutics Inc?
According to Atara Biotherapeutics Inc's FY2024 earnings report, its net investment of Atara Biotherapeutics Inc was 8.62M, with a year-on-year change of -93.04%.
What is the net financing of Atara Biotherapeutics Inc?
According to Atara Biotherapeutics Inc's FY2024 earnings report, its net financing of Atara Biotherapeutics Inc was 59.28M, with a year-on-year change of 2849.35%.
